These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer. Skopelitou D; Srivastava A; Miao B; Kumar A; Dymerska D; Paramasivam N; Schlesner M; Lubinski J; Hemminki K; Försti A; Reddy Bandapalli O Mol Genet Genomics; 2022 Jul; 297(4):965-979. PubMed ID: 35562597 [TBL] [Abstract][Full Text] [Related]
4. The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients. Chatrath A; Kiran M; Kumar P; Ratan A; Dutta A Mol Cancer Res; 2019 May; 17(5):1075-1086. PubMed ID: 30651372 [TBL] [Abstract][Full Text] [Related]
5. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases. Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863 [TBL] [Abstract][Full Text] [Related]
6. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series. Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405 [TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 tumor suppressor gene in families with multiple glioma patients. Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970 [TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing of Finnish hereditary breast cancer families. Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108 [TBL] [Abstract][Full Text] [Related]
11. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Andersson U; Wibom C; Cederquist K; Aradottir S; Borg A; Armstrong GN; Shete S; Lau CC; Bainbridge MN; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Houlston RS; Schildkraut J; Bernstein JL; Olson SH; Jenkins RB; Lachance DH; Wrensch M; Davis FG; Merrell R; Johansen C; Sadetzki S; ; Bondy ML; Melin BS Neuro Oncol; 2014 Oct; 16(10):1333-40. PubMed ID: 24723567 [TBL] [Abstract][Full Text] [Related]
12. Rare germline variants in known melanoma susceptibility genes in familial melanoma. Goldstein AM; Xiao Y; Sampson J; Zhu B; Rotunno M; Bennett H; Wen Y; Jones K; Vogt A; Burdette L; Luo W; Zhu B; Yeager M; Hicks B; Han J; De Vivo I; Koutros S; Andreotti G; Beane-Freeman L; Purdue M; Freedman ND; Chanock SJ; Tucker MA; Yang XR Hum Mol Genet; 2017 Dec; 26(24):4886-4895. PubMed ID: 29036293 [TBL] [Abstract][Full Text] [Related]
13. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698 [TBL] [Abstract][Full Text] [Related]
15. Whole-Exome Sequencing in 22 Young Ischemic Stroke Patients With Familial Clustering of Stroke. Ilinca A; Martinez-Majander N; Samuelsson S; Piccinelli P; Truvé K; Cole J; Kittner S; Soller M; Kristoffersson U; Tatlisumak T; Puschmann A; Putaala J; Lindgren A Stroke; 2020 Apr; 51(4):1056-1063. PubMed ID: 32172663 [TBL] [Abstract][Full Text] [Related]
16. Functional Common and Rare Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763 [TBL] [Abstract][Full Text] [Related]
17. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
18. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis. Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771 [TBL] [Abstract][Full Text] [Related]
19. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study. Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811 [TBL] [Abstract][Full Text] [Related]
20. Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study. Fewings E; Larionov A; Redman J; Goldgraben MA; Scarth J; Richardson S; Brewer C; Davidson R; Ellis I; Evans DG; Halliday D; Izatt L; Marks P; McConnell V; Verbist L; Mayes R; Clark GR; Hadfield J; Chin SF; Teixeira MR; Giger OT; Hardwick R; di Pietro M; O'Donovan M; Pharoah P; Caldas C; Fitzgerald RC; Tischkowitz M Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):489-498. PubMed ID: 29706558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]